In the context of pediatrics, gene editing has the potential to revolutionize the treatment of various genetic disorders that manifest early in life. Conditions such as cystic fibrosis, sickle cell anemia, and muscular dystrophy are caused by specific genetic mutations. By correcting these mutations at the genetic level, we can potentially offer cures rather than merely managing symptoms.
